Operating Lease, Right-of-Use Asset of Can-Fite BioPharma Ltd. from 31 Dec 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Can-Fite BioPharma Ltd. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Jun 2025.
  • Can-Fite BioPharma Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $91,000, a 47% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $91,000 +$29,000 +47% 30 Jun 2025 6-K 28 Aug 2025 2025 Q2
Q4 2024 $111,000 +$59,000 +113% 31 Dec 2024 6-K 28 Aug 2025 2025 Q2
Q2 2024 $62,000 -$25,000 -29% 30 Jun 2024 6-K 29 Aug 2024 2024 Q2
Q4 2023 $52,000 -$32,000 -38% 31 Dec 2023 20-F 14 Apr 2025 2024 FY
Q2 2023 $87,000 -$24,000 -22% 30 Jun 2023 6-K 31 Aug 2023 2023 Q2
Q4 2022 $84,000 -$54,000 -39% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q2 2022 $111,000 +$34,000 +44% 30 Jun 2022 6-K 25 Aug 2022 2022 Q2
Q4 2021 $138,000 +$65,000 +89% 31 Dec 2021 20-F 30 Mar 2023 2022 FY
Q2 2021 $77,000 +$11,000 +17% 30 Jun 2021 6-K 26 Aug 2021 2021 Q2
Q4 2020 $73,000 -$9,000 -11% 31 Dec 2020 20-F 24 Mar 2022 2021 FY
Q2 2020 $66,000 30 Jun 2020 6-K 27 Aug 2020 2020 Q2
Q4 2019 $82,000 31 Dec 2019 20-F 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.